Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NETWORK × Mesothelioma, Malignant × Clear all

Phase

Status

Completed 8 Unknown 1 Terminated 1

Sponsor Class

OTHER 16 INDUSTRY 12 NIH 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Ovarian Neoplasms 19 Breast Neoplasms 18 Lymphoma 17 Lung Neoplasms 16 Carcinoma, Ovarian Epithelial 15 Neoplasm Metastasis 14 Colorectal Neoplasms 14 Sarcoma 12 Squamous Cell Carcinoma of Head and Neck 11 Head and Neck Neoplasms 11 Prostatic Neoplasms 10 Urinary Bladder Neoplasms 9 Rectal Neoplasms 9 Colonic Neoplasms 9 Central Nervous System Neoplasms 9 Astrocytoma 9 Mycosis Fungoides 8 Multiple Myeloma 8 Adenocarcinoma of Lung 8 Uterine Cervical Neoplasms 7 Recurrence 7 Oligodendroglioma 7 Melanoma 7 Stomach Neoplasms 6 Sezary Syndrome 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Medulloblastoma 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, Large B-Cell, Diffuse 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02863055 2025-09-19

NEMO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡